Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. 2012

Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

BACKGROUND Patients with schizophrenia show increased brain and cerebrospinal fluid (CSF) concentrations of the endogenous N-methyl-D-aspartate receptor antagonist kynurenic acid (KYNA). This compound is an end-metabolite of the kynurenine pathway, and its formation indirectly depends on the activity of kynurenine 3-monooxygenase (KMO), the enzyme converting kynurenine to 3-hydroxykynurenine. METHODS We analyzed the association between KMO gene polymorphisms and CSF concentrations of KYNA in patients with schizophrenia and healthy controls. Fifteen single nucleotide polymorphisms (SNPs) were selected covering KMO and were analyzed in UNPHASED. RESULTS We included 17 patients with schizophrenia and 33 controls in our study. We found an association between a KMO SNP (rs1053230), encoding an amino acid change of potential importance for substrate interaction, and CSF concentrations of KYNA. CONCLUSIONS Given the limited sample size, the results are tentative until replication. CONCLUSIONS Our results suggest that the nonsynonymous KMO SNP rs1053230 influences CSF concentrations of KYNA.

UI MeSH Term Description Entries
D007736 Kynurenic Acid A broad-spectrum excitatory amino acid antagonist used as a research tool. Kynurenate,Acid, Kynurenic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D050601 Kynurenine 3-Monooxygenase An NADPH-dependent flavin monooxygenase that plays a key role in the catabolism of TRYPTOPHAN by catalyzing the HYDROXYLATION of KYNURENINE to 3-hydroxykynurenine. It was formerly characterized as EC 1.14.1.2 and EC 1.99.1.5. Kynurenine 3-Hydroxylase,Kynurenine Hydroxylase,L-Kynurenine-3-Hydroxylase,3-Hydroxylase, Kynurenine,3-Monooxygenase, Kynurenine,Hydroxylase, Kynurenine,Kynurenine 3 Hydroxylase,Kynurenine 3 Monooxygenase,L Kynurenine 3 Hydroxylase
D056726 Genetic Association Studies The analysis of a sequence such as a region of a chromosome, a haplotype, a gene, or an allele for its involvement in controlling the phenotype of a specific trait, metabolic pathway, or disease. Candidate Gene Identification,Candidate Gene Analysis,Candidate Gene Association Studies,Candidate Gene Association Study,Gene Discovery,Genotype-Phenotype Association,Genotype-Phenotype Associations,Genotype-Phenotype Correlation,Genotype-Phenotype Correlations,Analyses, Candidate Gene,Analysis, Candidate Gene,Association Studies, Genetic,Association Study, Genetic,Association, Genotype-Phenotype,Associations, Genotype-Phenotype,Candidate Gene Analyses,Correlation, Genotype-Phenotype,Correlations, Genotype-Phenotype,Discovery, Gene,Gene Analyses, Candidate,Gene Analysis, Candidate,Gene Identification, Candidate,Genetic Association Study,Genotype Phenotype Association,Genotype Phenotype Associations,Genotype Phenotype Correlation,Genotype Phenotype Correlations,Identification, Candidate Gene,Studies, Genetic Association,Study, Genetic Association
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
August 2022, Pharmaceuticals (Basel, Switzerland),
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
June 2014, Genetika,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
October 2023, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
May 2012, Schizophrenia bulletin,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
July 2018, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
August 2018, Neuropharmacology,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
January 2021, Frontiers in pharmacology,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
August 2022, Nordic journal of psychiatry,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
May 2012, Brain research,
Maria Holtze, and Peter Saetre, and Göran Engberg, and Lilly Schwieler, and Thomas Werge, and Ole A Andreassen, and Håkan Hall, and Lars Terenius, and Ingrid Agartz, and Erik G Jönsson, and Martin Schalling, and Sophie Erhardt
March 1997, Pediatric research,
Copied contents to your clipboard!